MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) will showcase several recent developments in next-generation AI solutions at the 109 th Scientific Assembly and Annual Meeting of the ...
Hologic HOLX is a long-standing innovator in developing and advancing technologies to help detect and treat breast cancer. The Massachusetts-based MedTech firm rang the Nasdaq opening bell for the ...
Leader in Women’s Health Will Unveil Groundbreaking Innovations With a Focus on Imaging Solutions and Artificial Intelligence Experience the cutting-edge Envision™ Mammography Platform (Graphic: ...
Shares of Hologic HOLX closed the first trading session of the year at $74.56, which is quite close to the 52-week high of $75.34, reached on Dec. 15, 2025. In the past six months, the company has ...
Hologic is currently moving through a take-private process by private equity firms, Blackstone and TPG. The transaction, pending Hologic stockholders’ approval, offers $76 per share in cash plus a ...
Hologic has been outperforming peers but underperforming the broader medical device sector, with shares up about 5% since my last analysis. Fiscal Q3 results showed consistent beats in Diagnostics, ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a ...
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) will reveal new technologies reimagining the future of breast health at the 110 th Scientific Assembly and Annual Meeting of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback